Positive Reactivity of Dysplastic Melanocytes with a Monoclonal Antibody Against Melanoma Melanosomes, MoAb HMSA-2
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 91 (3), 247-250
- https://doi.org/10.1111/1523-1747.ep12470378
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Development of MoAB HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytesCancer, 1987
- Human Monoclonal Antibodies That Distinguish Cutaneous Malignant Melanomas from Benign Nevi in Fixed Tissue SectionsJournal of Investigative Dermatology, 1986
- Fine structural characterization of melanosomes in dysplastic neviCancer, 1985
- Monoclonal Antibodies Selected to Discriminate Between Malignant Melanomas and Nevocellular NeviJournal of Investigative Dermatology, 1985
- Monoclonal Antibody to a Highly Glycosylated Protein Reacts in Fixed Tissue With Melanoma and Other TumorsHybridoma, 1985
- Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.Journal of Clinical Pathology, 1984
- Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomasJournal of the American Academy of Dermatology, 1983
- The dysplastic nevus syndrome Our definitionThe American Journal of Dermatopathology, 1982
- Characterization of Biochemical Properties of Melanosomes for Structural and Functional Differentiation: Analysis of the Compositions of Lipids and Proteins in Melanosomes and Their SubfractionsJournal of Investigative Dermatology, 1982
- Characterization of Structural Properties for Morphological Differentiation of Melanosomes: I. Purification of Tyrosinase by Tyrosine Affinity Chromatography and its Characterization in B16 and Harding Passey MelanomasJournal of Investigative Dermatology, 1981